Drug Shortage Report for SIMULECT
| Report ID | 232638 |
| Drug Identification Number | 02242815 |
| Brand name | SIMULECT |
| Common or Proper name | SIMULECT 20MG 1 X 1 VIALS |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BASILIXIMAB |
| Strength(s) | 20MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 X 1 |
| ATC code | L04AC |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-08-14 |
| Actual start date | |
| Estimated end date | 2024-09-03 |
| Actual end date | 2024-09-09 |
| Shortage status | Resolved |
| Updated date | 2024-09-10 |
| Company comments | Product on allocation to minimize patient impact and avoid stock out at market level. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2024-09-10 | English | Compare |
| v11 | 2024-09-09 | French | Compare |
| v10 | 2024-09-09 | English | Compare |
| v9 | 2024-08-15 | English | Compare |
| v8 | 2024-08-12 | French | Compare |
| v7 | 2024-08-12 | English | Compare |
| v6 | 2024-08-02 | English | Compare |
| v5 | 2024-07-10 | English | Compare |
| v4 | 2024-07-10 | French | Compare |
| v3 | 2024-07-10 | English | Compare |
| v2 | 2024-07-10 | French | Compare |
| v1 | 2024-07-10 | English | Compare |
Showing 1 to 12 of 12